New standard of disclosure set for clinical trials
- 12 October 2004
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 171 (8) , 839
- https://doi.org/10.1503/cmaj.1041506
Abstract
The New York State Attorney General's office is heralding a “new standard of disclosure” for clinical trial findings after reaching an agreement with GlaxoSmithKline to settle a lawsuit that alleged GSK committed consumer fraud by concealing studies indicating the antidepressant paroxetine couldThis publication has 0 references indexed in Scilit: